NCT07073183
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07073183
Title Safety and Tolerability of CVHNLC Plus Pembrolizumab in Patients With Squamous Non Small-Cell Lung Cancer (sqNSCLC)
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors CureVac
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | FRA | ESP


No variant requirements are available.